AIM ImmunoTech Inc. (AIM)
NYSE
0.2540
-0.0060 (-2.31%)
Closed
Aug 24, 2026
Day's Range
0.24670.2582
52 wk Range
0.19002.89
Financial Statements - AIM - AIM ImmunoTech Inc.
Revenue
88.00K▼ 48.2%
Net Income
-13.95M▲ 19.4%Net Margin -15861.4%
EBITDA
-12.68M▲ 20.4%
Free Cash Flow
-11.33M▲ 26.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 88K | 170K |
| Cost of Goods | 128K | 31K |
| Gross Profit | -40K | 139K |
 Operating Expense | - | - |
| Operating Income | -11.66M | -19.77M |
| Non-Operating Interest | - | - |
| Other Income Expense | -4.66M | -2.15M |
| Pre Tax Income | -13.95M | -17.32M |
| Income Tax | - | - |
| Net Income | -13.95M | -17.32M |
| EPS Basic | -8.62 | -30.969031 |
| EPS Diluted | -8.62 | -30.969031 |
| Basic Shares Outstanding | 1.61M | 560.72K |
| Diluted Shares Outstanding | 1.61M | 560.72K |
| Ebit | -13.14M | -16.73M |
| Ebitda | -12.68M | -15.93M |
| Net Income Continuous Operations | -13.95M | -17.32M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
